XML 88 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
INVESTMENT SECURITIES (Details) (USD $)
9 Months Ended 12 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Sep. 30, 2014
U.S. Treasury securities and U.S. Government agencies
Dec. 31, 2013
U.S. Treasury securities and U.S. Government agencies
Sep. 30, 2014
Private label mortgage backed security
Dec. 31, 2013
Private label mortgage backed security
Sep. 30, 2014
Mortgage backed securities - residential
Dec. 31, 2013
Mortgage backed securities - residential
Sep. 30, 2014
Collateralized mortgage obligations
Dec. 31, 2013
Collateralized mortgage obligations
Sep. 30, 2014
Federal Home Loan Mortgage Corporation Certificates and Obligations FHLMC Preferred Stock [Member]
Dec. 31, 2008
Federal Home Loan Mortgage Corporation Certificates and Obligations FHLMC Preferred Stock [Member]
Sep. 30, 2014
Mutual fund
Dec. 31, 2013
Mutual fund
Dec. 31, 2013
Corporate bonds
Sep. 30, 2014
Corporate bonds
Mar. 31, 2014
Corporate bonds
Securities available for sale:                                    
Gross Amortized Cost $ 445,292,000   $ 428,263,000 $ 149,709,000 $ 97,157,000 $ 4,158,000 $ 4,740,000 $ 125,058,000 $ 146,087,000 $ 150,355,000 $ 164,264,000     $ 1,000,000 $ 1,000,000 $ 15,015,000 $ 15,012,000  
Gross Unrealized Gains 8,757,000   6,720,000 257,000 409,000 1,179,000 745,000 5,363,000 4,288,000 1,167,000 1,228,000 669,000   10,000   50,000 112,000  
Gross Unrealized Losses (1,075,000)   (2,090,000) (75,000) (101,000)     (156,000) (288,000) (844,000) (1,546,000)       (5,000) (150,000)    
Fair Value 452,974,000   432,893,000 149,891,000 97,465,000 5,337,000 5,485,000 130,265,000 150,087,000 150,678,000 163,946,000 669,000 0 1,010,000 995,000 14,915,000 15,124,000  
Amount of floating rate corporate bonds purchased $ 119,427,000 $ 175,275,000                           $ 20,000,000    
Weighted average yield (as a percent)                               1.36%    
Weighted average life                               7 years    
Corporate bonds as a percentage of bank's investment portfolio                               4.00%   4.00%